Emerging Therapies in the Management of HR+, HER2- Metastatic Breast Cancer - Episode 4
Approaches to Repeat Hormone Receptor and HER2 Status Testing Before Initiating Later Lines of Therapy
Laura Huppert, MD, and Yara Abdou, MD, review approaches to repeat hormone receptor and HER2 status testing before initiating later lines of therapy in patients with metastatic breast cancer.
Video Player is loading.
This is a modal window.
The Playback API request failed for an unknown reason
Error Code: VIDEO_CLOUD_ERR_UNKNOWN
Technical details
:
Session ID: 2025-05-19:dbec46e2d91272ae9f87153a Player Element ID: vjs_video_812
Related Content:
